FIRMVERO
Commercial launch is on hold. Demos remain available as read-only fictional examples.Explore demos
All demos

DEMO — Not offered for sale.

Read-only fictional example. Inquiries, confidential access, invitations, purchases and sample interactions are unavailable. This business is not offered for sale.

Experience this business.

Explore the Cinematic Showcase — a scroll-driven demo experience.

Experience This Business
Illustrative synthetic image for Specialty Pharmacy demo opportunity

Specialty Pharmacy

Phoenix, AZ

Healthcare

Business Overview

Independent specialty pharmacy with recurring payer contracts and a long-tenured pharmacist team.

Highlights

Confidential Recurring Revenue Seller Transition Available

Firmvero Deal Intelligence

Deal Score summarizes structured signals from available listing data. It is not a valuation or recommendation.

Deal Score

57

Evidence Coverage: 45%

Basis: adjusted_ebitda

Structured Strengths

  • Positive reported Adjusted EBITDA.
  • Asking-price-to-Adjusted EBITDA relationship is calculable (4.55x).
  • Revenue durability signals present (recurring-revenue).
  • Operating transferability signals present (seller-transition-available).

Unknowns

  • Historical financial trend is not established from current marketplace data.
  • Historical P&Ls are not available in the marketplace data.
  • Customer concentration is not established from current marketplace data.
  • Lease terms are not established from current marketplace data.
  • Financial verification has not been established.

Score Dimensions

Financial Performance 70/100

Positive Adjusted EBITDA with a 16.5% margin.

Price / Cash Flow 70/100

Asking price implies a 4.55x Adjusted EBITDA multiple.

Revenue Durability 33/100

1 durability signal(s) present.

Operating Transferability 60/100

1 transferability signal(s) present.

Transaction Flexibility 0/100

No transaction flexibility signals present.

Financial Trend UNKNOWN

Multiple comparable periods are not available to establish a trend.

Diligence Questions

  • HIGH Please provide at least three years of historical P&L statements.
  • HIGH What adjustments reconcile reported EBITDA to adjusted EBITDA?
  • MEDIUM What percentage of revenue is recurring, and what contracts or subscriptions support it?
  • HIGH What percentage of revenue is generated by the five largest customers?
  • HIGH What are the remaining lease term, renewal options, rent escalations, and assignment requirements?
  • HIGH What licenses and regulatory approvals are required, and are they transferable?
  • HIGH What is the payer or client concentration across the largest referral sources?